DEF fragment 3, a close match of chemical shift data was found
between 4 and 15 and the spirastrellolide methyl ester (2),2 with all
substituents on the DE-ring spiroacetal equatorial. Additionally, a
diagnostic NOE enhancement was observed between H27 and H38,
consistent with the bis-spiroacetal possessing the doubly anomeric
effect-stabilised configuration at C31 and C35.
In conclusion, we have developed an improved approach to the
construction of the challenging C26–C40 DEF region of the marine
macrolide spirastrellolide, employing a novel double Sharpless
dihydroxylation/spiroacetalisation sequence, as in 16 A 15. This
eliminates the need for protecting groups and enhances the supply
of the northern hemisphere, enabling the initiation of fragment
coupling studies to unravel the remaining stereochemical ambi-
guities and further advance the total synthesis of this potent
bioactive polyketide.
We thank the EPSRC (EP/C541677/1), Merck Research
Laboratories, Homerton College, Cambridge (Research
Fellowship to E.A.A.), SK Corporation (J.H.L.) and the
German Academic Exchange Service (DAAD, Postdoctoral
Fellowship to C.M.) for support and Professor Raymond
Andersen (University of British Columbia) for helpful discussions.
Scheme 6 Reagents and conditions: (i) K2OsO2(OH)4, (DHQ)2PYR,
MeSO2NH2, K3Fe(CN)6, K2CO3, t-BuOH–H2O, 0 uC; (ii) PPTS (cat.),
DCM–MeOH (1 : 1); (iii) TESOTf, 2,6-lutidine, DCM, 278 uC; (iv) PPTS
(cat.), DCM–MeOH (6 : 1), 0 uC.
Notes and references
of reactions to those already described, 1,5-diketone 16 was
obtained on a gram scale in 47% yield.
1 K.-S. Yeung and I. Paterson, Chem. Rev., 2005, 105, 4237;
R. D. Norcross and I. Paterson, Chem. Rev., 1995, 95, 2041;
I. Paterson and E. A. Anderson, Science, 2005, 310, 451.
2 D. E. Williams, M. Roberge, R. Van Soest and R. J. Andersen, J. Am.
Chem. Soc., 2003, 125, 5296; D. E. Williams, M. Lapawa, X. Feng,
T. Tarling, M. Roberge and R. J. Andersen, Org. Lett., 2004, 6, 2607.
3 L. H. Le, C. Erlichman, L. Pillon, J. J. Thiessen, A. Day, N. Wainman,
E. A. Eisenhauer and M. J. Moore, Invest. New Drugs, 2004, 22, 159;
R. E. Honkanen and T. Golden, Curr. Med. Chem., 2002, 9, 2055.
4 I. Paterson, E. A. Anderson, S. M. Dalby and O. Loiseleur, Org. Lett.,
2005, 7, 4125.
We were now ready to perform the crucial double asymmetric
dihydroxylation reaction. Our original route5 utilised the
(DHQ)2PHAL ligand for the internal olefin, whilst the
(DHQ)2PYR ligand was optimal for the terminal olefin. Guided
by this and other precedents,7 we opted for the latter conditions
(Scheme 6). In the event, exposure of diene 16 to Sharpless
conditions led to rapid (1 h) dihydroxylation of the internal olefin,
followed by reaction at the terminal double bond (3 h), where
NMR analysis indicated the formation of a complex mixture of
isomeric products 21. As purification did not prove fruitful,
the crude reaction mixture was exposed to PPTS in DCM–MeOH
(1 : 1), leading to cyclisation to give the targeted DEF subunit 15,
together with other isomers.
5 I. Paterson, E. A. Anderson, S. M. Dalby and O. Loiseleur, Org. Lett.,
2005, 7, 4121.
6 For other synthetic studies, see: J. Liu and R. P. Hsung, Org. Lett.,
2005, 7, 2273; I. Paterson, E. A. Anderson and S. M. Dalby, Synthesis,
2006, 3225; Y. Pan and J. K. De Brabander, Synlett, 2006, 853; C. Wang
and C. J. Forsyth, Org. Lett., 2006, 8, 2997; A. Fu¨rstner, M. D. B.
Fenster, B. Fasching, C. Godbout and K. Radkowski, Angew. Chem.,
Int. Ed., 2006, 45, 5506; A. Fu¨rstner, M. D. B. Fenster, B. Fasching,
C. Godbout and K. Radkowski, Angew. Chem., Int. Ed., 2006, 45, 5510;
J. Liu, J. H. Yang, C. Ko and R. P. Hsung, Tetrahedron Lett., 2006, 47,
6121.
7 H. C. Kolb, M. S. VanNieuwenhze and K. B. Sharpless, Chem. Rev.,
1994, 94, 2483.
8 C. Garc´ıa, T. Mart´ın and V. S. Mart´ın, J. Org. Chem., 2001, 66, 1420;
N. Ragoussis, Tetrahedron Lett., 1987, 28, 93.
9 H. C. Brown and K. S. Bhat, J. Am. Chem. Soc., 1986, 108, 293.
10 I. Paterson, K.-S. Yeung and J. B. Smaill, Synlett, 1993, 774.
11 W. S. Mahoney, D. M. Brestensky and J. M. Stryker, J. Am. Chem.
Soc., 1988, 110, 291.
12 Varying amounts of a dihydropyran side-product i were isolated from
this oxidation; this could be readily recycled to the oxidation substrate
upon exposure to PPTS in THF–water.
The use of PPTS for this equilibration/cyclisation process was
found to be essential, as stronger acids (CSA, HCl) led to
competitive formation of furan-containing by-products. To over-
come material losses in the chromatographic isolation of 15,
protection of the crude mixture of isomeric DEF diols was carried
out (TESOTf, 2,6-lutidine). The resulting silylated products now
proved more stable to purification and the desired DEF bis-
spiroacetal 22 was readily separated from other isomers.
Pleasingly, these other isomers could be recycled via re-exposure
to PPTS in DCM–MeOH (1 : 1), which cleaved both TES ethers
and effected spiroacetal equilibration without competing elimina-
tion side-reactions. Subsequent reprotection afforded more of the
targeted DEF tricycle 22, giving a 65% yield overall from 16 after
one recycle. Finally, to enable investigation of fragment union with
the southern hemisphere,4 the primary TES ether was selectively
cleaved using PPTS (DCM–MeOH, 6 : 1, 0 uC) leading to the fully
functionalised DEF subunit 4 (93%).
13 I. Paterson, D. J. Wallace and C. J. Cowden, Synthesis, 1998, 689.
14 I. Paterson, D. J. Wallace and S. M. Vela´zquez, Tetrahedron Lett., 1994,
35, 9083.
The stereochemistry of the newly formed bis-spiroacetals was
confirmed using 1H NMR spectroscopy. As with our previous
15 I. Paterson and D. J. Wallace, Tetrahedron Lett., 1994, 35, 9087.
4188 | Chem. Commun., 2006, 4186–4188
This journal is ß The Royal Society of Chemistry 2006